LOS ANGELES--(BUSINESS WIRE)--The Alfred Mann Foundation for Scientific Research (AMF), a leading innovator in medical technology, today welcomed Eric Grigsby (MD, MBA) to its team as the Chief Medical Officer. The Alfred Mann Foundation is a non-profit organization dedicated to developing and commercializing innovative solutions for significant unmet medical conditions.
“Eric Grigsby cares first and foremost about producing great patient outcomes and as such is an outstanding addition to AMF’s team of scientists, engineers and clinicians. Eric is widely recognized around the globe as a leader in pain relief and neuromodulation. His medical and clinical expertise, as well as his business acumen will enable him to play a key role as AMF develops new, leading edge medical products to address unmet medical needs,” said David Hankin, Chief Executive Officer at the Alfred Mann Foundation.
Dr. Grigsby is the former President and Chief Executive Officer of Neurovations, a Clinical Research and Consulting company specializing in pain and neurologic disease. Dr. Grigsby is also the Founder and Medical Director of Napa Pain Institute in Napa, California. He continues to practice as a board certified Pain Physician. Dr. Grigsby graduated from Brown University with an undergraduate degree in Biology and Economics. He then completed medical school at Boston University School of Medicine, and completed residency training in Anesthesiology and Pain Medicine at the Mayo Clinic in Rochester, Minnesota. He received his Masters in Business Administration, in Health Sector Management, from Duke University. Professionally, Dr. Grigsby was Director of the hospital pain service at Mayo Clinic, and was later Founding Director of the University of California at Davis Pain Center. He has been in private practice of pain management in Napa, California for 20 years. At Neurovations, Dr. Grigsby collaborated with some of the world’s finest scientists, industry leaders and clinicians, to help shorten the innovation cycle of products for better treatment of pain and neurologic diseases.
“After thirty years of clinical medicine, it’s clear to me that we do not have the necessary tools to help solve our biggest clinical challenges, especially for patients with long term chronic illness,” said Grigsby. “I’m excited to bring my experience in patient care and in product development to the Alfred Mann Foundation. The Foundation has the people, leadership, resources, and a proven track record of success in medical device development. I’m eager to partner with them as Chief Medical Officer. I know that together we will bring new therapies more quickly to our patients in need.”
About the Alfred Mann Foundation
Founded in 1985 by serial healthcare entrepreneur Alfred E. Mann, the Alfred Mann Foundation for Scientific Research has developed a myriad of medical devices that change the lives of patients across the globe, including the cochlear implant that enables deaf people to hear, several diabetes products, numerous products in the neural space for the eradication of pain and recovery of function. AMF is located in Santa Clarita, California.
Contacts
Rogers & Cowan
Steve Doctrow, 310-854-8130
SDoctrow@RogersandCowan.com
or
Caroline Stegner, 310-854-8149
CStegner@RogersandCowan.com
“Eric Grigsby cares first and foremost about producing great patient outcomes and as such is an outstanding addition to AMF’s team of scientists, engineers and clinicians. Eric is widely recognized around the globe as a leader in pain relief and neuromodulation. His medical and clinical expertise, as well as his business acumen will enable him to play a key role as AMF develops new, leading edge medical products to address unmet medical needs,” said David Hankin, Chief Executive Officer at the Alfred Mann Foundation.
Dr. Grigsby is the former President and Chief Executive Officer of Neurovations, a Clinical Research and Consulting company specializing in pain and neurologic disease. Dr. Grigsby is also the Founder and Medical Director of Napa Pain Institute in Napa, California. He continues to practice as a board certified Pain Physician. Dr. Grigsby graduated from Brown University with an undergraduate degree in Biology and Economics. He then completed medical school at Boston University School of Medicine, and completed residency training in Anesthesiology and Pain Medicine at the Mayo Clinic in Rochester, Minnesota. He received his Masters in Business Administration, in Health Sector Management, from Duke University. Professionally, Dr. Grigsby was Director of the hospital pain service at Mayo Clinic, and was later Founding Director of the University of California at Davis Pain Center. He has been in private practice of pain management in Napa, California for 20 years. At Neurovations, Dr. Grigsby collaborated with some of the world’s finest scientists, industry leaders and clinicians, to help shorten the innovation cycle of products for better treatment of pain and neurologic diseases.
“After thirty years of clinical medicine, it’s clear to me that we do not have the necessary tools to help solve our biggest clinical challenges, especially for patients with long term chronic illness,” said Grigsby. “I’m excited to bring my experience in patient care and in product development to the Alfred Mann Foundation. The Foundation has the people, leadership, resources, and a proven track record of success in medical device development. I’m eager to partner with them as Chief Medical Officer. I know that together we will bring new therapies more quickly to our patients in need.”
About the Alfred Mann Foundation
Founded in 1985 by serial healthcare entrepreneur Alfred E. Mann, the Alfred Mann Foundation for Scientific Research has developed a myriad of medical devices that change the lives of patients across the globe, including the cochlear implant that enables deaf people to hear, several diabetes products, numerous products in the neural space for the eradication of pain and recovery of function. AMF is located in Santa Clarita, California.
Contacts
Rogers & Cowan
Steve Doctrow, 310-854-8130
SDoctrow@RogersandCowan.com
or
Caroline Stegner, 310-854-8149
CStegner@RogersandCowan.com
